Kathleen Rickard

4.4k total citations
83 papers, 3.3k citations indexed

About

Kathleen Rickard is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Kathleen Rickard has authored 83 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 57 papers in Physiology and 12 papers in Immunology and Allergy. Recurrent topics in Kathleen Rickard's work include Asthma and respiratory diseases (57 papers), Respiratory and Cough-Related Research (46 papers) and Inhalation and Respiratory Drug Delivery (23 papers). Kathleen Rickard is often cited by papers focused on Asthma and respiratory diseases (57 papers), Respiratory and Cough-Related Research (46 papers) and Inhalation and Respiratory Drug Delivery (23 papers). Kathleen Rickard collaborates with scholars based in United States, United Kingdom and Sweden. Kathleen Rickard's co-authors include Amanda Emmett, Steven W. Yancey, Stephen I. Rennard, Wayne H. Anderson, Christopher Kalberg, Nina L. Church, Donald A. Mahler, Michael Wisniewski, Katharine Knobil and James F. Donohue and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Kathleen Rickard

79 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Rickard United States 35 2.6k 2.5k 562 170 166 83 3.3k
Pierluigi Paggiaro Italy 29 2.8k 1.1× 2.4k 0.9× 571 1.0× 101 0.6× 311 1.9× 101 3.7k
Jorge Máspero United States 29 3.9k 1.5× 2.4k 0.9× 1.6k 2.8× 179 1.1× 97 0.6× 136 4.7k
Anjuli Nayak United States 26 1.8k 0.7× 922 0.4× 1.4k 2.4× 109 0.6× 41 0.2× 48 2.1k
Yamo Deniz United States 24 2.1k 0.8× 1.2k 0.5× 1.1k 1.9× 84 0.5× 92 0.6× 111 2.7k
René Aalbers Netherlands 24 1.6k 0.6× 1.5k 0.6× 323 0.6× 54 0.3× 86 0.5× 64 2.0k
David A. Mathison United States 22 1.9k 0.7× 1.2k 0.5× 639 1.1× 54 0.3× 132 0.8× 45 3.1k
Graeme P. Currie United Kingdom 25 990 0.4× 1.0k 0.4× 255 0.5× 54 0.3× 181 1.1× 109 1.7k
Jutta Beier Germany 23 1.1k 0.4× 1.3k 0.5× 174 0.3× 35 0.2× 177 1.1× 86 1.8k
Camille Taillé France 29 1.4k 0.5× 1.4k 0.6× 291 0.5× 347 2.0× 891 5.4× 162 3.1k
Krzysztof Sładek Poland 23 1.5k 0.6× 1.0k 0.4× 272 0.5× 42 0.2× 191 1.2× 117 2.3k

Countries citing papers authored by Kathleen Rickard

Since Specialization
Citations

This map shows the geographic impact of Kathleen Rickard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Rickard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Rickard more than expected).

Fields of papers citing papers by Kathleen Rickard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Rickard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Rickard. The network helps show where Kathleen Rickard may publish in the future.

Co-authorship network of co-authors of Kathleen Rickard

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Rickard. A scholar is included among the top collaborators of Kathleen Rickard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Rickard. Kathleen Rickard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dransfield, Mark T., Ravi Kalhan, Daniel Reyner, et al.. (2025). Ensifentrine in COPD patients taking long-acting bronchodilators: A pooled post-hoc analysis of the ENHANCE-1/2 studies. Chronic Respiratory Disease. 22. 4093739194–4093739194. 5 indexed citations
2.
3.
Sciurba, Frank C., Stephanie A. Christenson, Tara Rheault, et al.. (2024). Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD. CHEST Journal. 167(2). 425–435. 7 indexed citations
4.
Donohue, James F., et al.. (2023). Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of COPD. Volume 18. 1611–1622. 19 indexed citations
5.
Rickard, Kathleen, Tara Rheault, & Thomas Bengtsson. (2020). Additional Bronchodilation by Ensifentrine, A Dual PDE3/4 Inhibitor, When Combined with a LAMA/LABA in Patients with Moderate to Severe COPD. A4298–A4298. 4 indexed citations
6.
Donohue, James F., et al.. (2014). Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study. International Journal of COPD. 9. 745–745. 53 indexed citations
7.
Sheth, Ketan, Cindy K. Cook, E. Philpot, et al.. (2004). Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.. PubMed. 25(2). 115–20. 16 indexed citations
8.
Dykewicz, Mark S., Harold B. Kaiser, Robert A. Nathan, et al.. (2003). Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Annals of Allergy Asthma & Immunology. 91(1). 44–48. 34 indexed citations
9.
Leibman, Christopher, Dev S. Pathak, Paul Dorinsky, et al.. (2002). Cost-effectiveness analysis of fluticasone propionate/salmeterol combination versus montelukast in the treatment of adults with asthma. Journal of Allergy and Clinical Immunology. 109(1). S185–S185. 2 indexed citations
10.
Creticos, Peter S., Katharine Knobil, Lisa Edwards, Kathleen Rickard, & Paul Dorinsky. (2002). Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Annals of Allergy Asthma & Immunology. 88(4). 401–409. 36 indexed citations
11.
Calhoun, William J., Harold S. Nelson, Robert A. Nathan, et al.. (2001). Comparison of Fluticasone Propionate–Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting β2-Agonists Alone. American Journal of Respiratory and Critical Care Medicine. 164(5). 759–763. 54 indexed citations
12.
Rennard, Stephen I., Wayne H. Anderson, Richard ZuWallack, et al.. (2001). Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 163(5). 1087–1092. 198 indexed citations
13.
Ginchansky, Elliot, Bruce Friedman, Sharon Srebro, et al.. (2000). Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy. Annals of Allergy Asthma & Immunology. 85(5). 398–406. 32 indexed citations
14.
Nelson, Harold S., et al.. (1999). Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 159(5). 1556–1561. 47 indexed citations
15.
Chen, Jianjun, et al.. (1997). Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients. Journal of Gastroenterology and Hepatology. 12(2). 182–187. 9 indexed citations
16.
Robbins, Richard, Sekiya Koyama, John R. Spurzem, et al.. (1992). Modulation of Neutrophil and Mononuclear Cell Adherence to Bronchial Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 7(1). 19–29. 23 indexed citations
17.
Rickard, Kathleen, et al.. (1992). Observations of Development of Resistance to Detachment of Cultured Bovine Bronchial Epithelial Cells in Response to Protease Treatment. American Journal of Respiratory Cell and Molecular Biology. 6(4). 414–420. 19 indexed citations
18.
Rennard, Stephen I., Kathleen Rickard, John R. Spurzem, et al.. (1992). Airways Inflammation. CHEST Journal. 101(3). 30S–32S. 1 indexed citations
19.
Rennard, Stephen I., Kathleen Rickard, Joe D. Beckmann, et al.. (1991). Protease Injury in Airways Disease. Annals of the New York Academy of Sciences. 624(1). 278–285. 3 indexed citations
20.
Shoji, Shunsuke, Kathleen Rickard, Ronald F. Ertl, et al.. (1989). Bronchial Epithelial Cells Produce Lung Fibroblast Chemotactic Factor: Fibronectin. American Journal of Respiratory Cell and Molecular Biology. 1(1). 13–20. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierluigi Paggiaro Breakdown of academic impact, for papers by Jorge Máspero Breakdown of academic impact, for papers by Anjuli Nayak Breakdown of academic impact, for papers by Yamo Deniz Breakdown of academic impact, for papers by René Aalbers Breakdown of academic impact, for papers by David A. Mathison Breakdown of academic impact, for papers by Graeme P. Currie Breakdown of academic impact, for papers by Jutta Beier Breakdown of academic impact, for papers by Camille Taillé Breakdown of academic impact, for papers by Krzysztof Sładek
Rankless by CCL
2026